(Registrieren)

New ATP Tour App Designed by Infosys Brings Fans Closer to Pro Tennis Tours

Geschrieben am 08-11-2019

London (ots/PRNewswire) - Fans of men's professional tennis can
dive deeper than ever before into the ATP Tour and ATP Challenger
Tour following the release of the ATP's new official mobile app.

Developed in partnership with Infosys and available today for IOS
and Android devices, 'ATP Tour app' delivers official live scores,
stats, news and video and a personalised feed featuring fans'
favourite players and tournaments.

Additionally, through customised notifications, fans will be
alerted when their players begin or complete a match and immediately
when fresh news and video content about their favourite players has
been published. The app has been designed with the support of the
London-based design arm of Infosys, Brilliant Basics.

Pravin Rao, Chief Operating Officer, Infosys, said, "It's the 5th
year of our relationship with the ATP, and we are very excited to
continue this digital transformation journey with them. This new app
is built with best-in class principles of digital and design and has
been created with fans front and centre. It ties in with our overall
commitment to the sport, combining our passion for tennis and
technology to reimagine the sport for players and fans alike."

Chris Kermode, ATP Executive Chairman & President, said: "We're
delighted to announce the launch of the new ATP Tour app. The app
will enable tennis fans worldwide to follow the Tour and their
favourite players more closely than ever before as we continue to
leverage technology to increase engagement with the Tour's growing
fan base."

Highlights of the new app include:

- Official point-by-point live scoring of all ATP Tour and ATP
Challenger Tour tournaments
- A personalised news feed providing immediate access to the latest
content on favourite players and tournaments
- Detailed player bio, data and match statistics
- Daily schedules, draws and results from all ATP Tour and Challenger
Tour tournaments
- Official ATP Race & Rankings tables
- Latest news, videos and features on the game's most exciting
players and tournaments
- Detailed FedEx ATP Head2Head rivalry information
- Full ATP Tour & Challenger Tour calendar

About the ATP

The ATP is the governing body of the men's professional tennis
circuits - the ATP Tour, the ATP Challenger Tour and the ATP
Champions Tour. With 64 tournaments in 30 countries, the 2019 ATP
Tour showcases the finest male athletes competing in the world's most
exciting venues. From Australia to Europe and the Americas to Asia,
the stars of the 2019 ATP Tour will battle for prestigious titles and
ATP Rankings points at ATP Masters 1000, 500 and 250 events, as well
as Grand Slams (non-ATP events). At the end of the season only the
world's top 8 qualified singles players and doubles teams will
qualify to compete for the last title of the season at the Nitto ATP
Finals. Held at The O2 in London, the event will officially crown the
2019 ATP Tour No. 1. For more information, please visit
www.ATPTour.com.

About Infosys

Infosys is a global leader in next-generation digital services and
consulting. We enable clients in 46 countries to navigate their
digital transformation. With over three decades of experience in
managing the systems and workings of global enterprises, we expertly
steer our clients through their digital journey. We do it by enabling
the enterprise with an AI-powered core that helps prioritize the
execution of change. We also empower the business with agile digital
at scale to deliver unprecedented levels of performance and customer
delight. Our always-on learning agenda drives their continuous
improvement through building and transferring digital skills,
expertise, and ideas from our innovation ecosystem.

Visit www.infosys.com to see how Infosys (NYSE: INFY) can help
your enterprise navigate your next.

Safe Harbor

Certain statements mentioned in this release concerning our future
growth prospects and our future business expectations are
forward-looking statements intended to qualify for the 'safe harbor'
under the Private Securities Litigation Reform Act of 1995. Such
statements involve a number of risks and uncertainties that could
cause actual results to differ materially from those in such
forward-looking statements. The risks and uncertainties relating to
these statements include, but are not limited to, risks and
uncertainties regarding fluctuations in earnings, fluctuations in
foreign exchange rates, our ability to manage growth, intense
competition in IT services including those factors which may affect
our cost advantage, wage increases in India, our ability to attract
and retain highly skilled professionals, time and cost overruns on
fixed-price, fixed-time frame contracts, client concentration,
restrictions on immigration, industry segment concentration, our
ability to manage our international operations, reduced demand for
technology in our key focus areas, disruptions in telecommunication
networks or system failures, our ability to successfully complete and
integrate potential acquisitions, liability for damages on our
service contracts, the success of the companies in which Infosys has
made strategic investments, withdrawal or expiration of governmental
fiscal incentives, political instability and regional conflicts,
legal restrictions on raising capital or acquiring companies outside
India, and unauthorized use of our intellectual property and general
economic conditions affecting our industry. Additional risks that
could affect our future operating results are more fully described in
our United States Securities and Exchange Commission filings
including our Annual Report on Form 20-F for the fiscal year ended
March 31, 2019. These filings are available at www.sec.gov. Infosys
may, from time to time, make additional written and oral
forward-looking statements, including statements contained in the
company's filings with the Securities and Exchange Commission and our
reports to shareholders. The company does not undertake to update any
forward-looking statements that may be made from time to time by or
on behalf of the company unless it is required by law

For further information, please contact: PR_Global@infosys.com

Logo: https://mma.prnewswire.com/media/633365/Infosys_Logo.jpg

ots Originaltext: INFOSYS
Im Internet recherchierbar: http://www.presseportal.de

Original-Content von: INFOSYS, übermittelt durch news aktuell


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

709549

weitere Artikel:
  • International Health Forum 2019: Künstliche Intelligenz - wo liegen die größten Chancen für den Healthcare-Markt? - Strategiekonferenz für 200 Top-Manager heute beim Wort & Bild Verlag in Baierbru Baierbrunn (ots) - Künstliche Intelligenz (KI), lernende Maschinen, KI-getriebene Kommunikation - wo liegen die größten Chancen beim Thema Artificial Intelligence, und wie lassen sie sich im Healthcare-Business umsetzen? Das diskutieren heute über 200 Top-Manager beim 24. International Health Forum des Wort & Bild Verlags. Die ganztägige "Invitation-only-Strategiekonferenz" hat zum Ziel, unabhängig vom Tagesgeschäft einen Blick auf weltweite innovative Entwicklungen zu ermöglichen. Internationale Experten und herausragende junge mehr...

  • Veröffentlichungstermine des Statistischen Bundesamtes (DESTATIS) vom 11.11.2019 bis 15.11.2019 Wiesbaden (ots) - (die Veröffentlichungen erfolgen in der Regel um 8.00 Uhr) Montag, 11.11.2019 (Nr.433) Indizes der Großhandelspreise, Oktober 2019 Dienstag, 12.11.2019 (Nr. 46) Zahl der Woche: Kleinste, größte und die am dichtesten besiedelte Gemeinde Deutschlands, Jahr 2018 Mittwoch, 13.11.2019 (Nr. 434) Verbraucherpreisindex (inklusive Harmonisierter Verbraucherpreisindex), endgültige Ergebnisse, Oktober 2019 (Nr. 435) Einschulungen (Schnellmeldung), Schuljahr 2019/2020 Donnerstag, 14.11.2019 (Nr. 436) Bruttoinlandsprodukt mehr...

  • TalentMetropole Ruhr zeichnet fünf Vorbilder für erfolgreiche Nachwuchsförderung aus (FOTO) Essen (ots) - - TalentAward Ruhr 2019 vor 700 Gästen im Essener thyssenkrupp Quartier verliehen - Preis ist mit insgesamt 25.000 Euro dotiert - Bärbel Bergerhoff-Wodopia, Bildungsbeauftragte und Vorstandsmitglied der RAG-Stiftung: Aufsteiger brauchen Förderer Große Bühne für erfolgreiche Nachwuchsförderer: Mit dem TalentAward Ruhr hat die TalentMetropole Ruhr, Leitprojekt Bildung des Initiativkreises Ruhr, am Donnerstag, 7. November 2019, fünf beeindruckende Beispiele für Talentförderung ausgezeichnet. Der vor mehr...

  • Omega-3 fatty-acid enriched parenteral nutrition improves patient outcomes BAD HOMBURG, GERMANY (ots) - A new systematic literature review and meta-analysis1 confirms and extends previous results that omega-3 (omega-3) fatty-acid enriched parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients. Including a total of 49 randomized controlled trials (RCTs), this literature review provides the most extensive and up-to-date analysis* of the effect of omega-3 fatty-acid enriched PN on patient outcomes. According to this analysis, adding omega-3 fatty acids to PN significantly mehr...

  • Mit omega-3-Fettsäuren angereicherte parenterale Ernährung verbessert Patientenergebnisse Bad Homburg (ots) - Eine neue systematische Literaturübersicht und Metaanalyse1 bestätigt und erweitert bisherige Ergebnisse, denen zufolge mit mega-3 (omega-3) Fettsäuren angereicherte parenterale Ernährung (PE) bei erwachsenen Patienten bessere klinischen Ergebnis erzielt als Standard-PE. Mit insgesamt 49 randomisierten kontrollierten Studien (RCTs) bietet diese Literaturübersicht die umfassendste und aktuellste Analyse* der Auswirkung von mit omega-3-Fettsäuren angereicherter PE auf die Patientenergebnisse. Dieser Analyse zufolge mehr...

Mehr zu dem Thema Aktuelle Wirtschaftsnews

Der meistgelesene Artikel zu dem Thema:

DBV löst Berechtigungsscheine von knapp 344 Mio. EUR ein

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht